[1]
L. A. Martínez López and C. García García, “Monitored Dosage Systems in Diabetic Patients Follow-Up: Drug Related Problems Due to Excipients”, Pharm Care Esp, vol. 23, no. 5, pp. 42–48, Oct. 2021.